In today’s healthcare services, it is more important than ever to demonstrate economic value. England, Scotland, Wales, Ireland and many other European countries have health technology assessment (HTA) bodies that assess the cost-effectiveness of a product, as well as its clinical efficacy.
Hayward has strong relationships with a variety of independent and academic institution-associated health economic (HE) groups who have a solid track record of working on HTA submissions. Partnering with well-respected HE units allows Hayward to adopt flexible approaches to best satisfy the requirements of the HTA bodies.
Hayward has established relationships with many of the UK’s leading health economists, including commercial alliances with:
This means we can draw on the best experts to build economic and budget impact models, based on the expertise required, your objectives and your budget, no matter what the disease area or level of complexity.
Our service goes beyond modelling for HTA submissions. You may need to produce a health economic review or publish a business case to inform pharmacists and budget holders of the impact of your product. You may need a simple, dynamic way to demonstrate the budget impact of your product on a local health economy. With our long publishing history and digital experience, we are ideally placed to help.
To find out more about how we can help you, call +44(0)1638 723560 or email Paul Thomas